BACKGROUND: The purpose of this prospective study was to assess the quality of life (QOL) and oral functioning of patients with oral cancer up to 5 years after prosthodontic rehabilitation with mandibular implant-retained overdentures. METHODS: Fifty patients who had received implants during ablative surgery were evaluated by standardized questionnaires before and after oncological and prosthetic treatment. RESULTS: In 20 of 24 surviving patients, the dentures were functional after 5 years. In these survivors, oral function remained unchanged during this period. In the 6 patients with concurrent comorbidity, global health and QOL had deteriorated, while in the patients without comorbidity, global health and QOL were very high. Five-year survivors had a higher global health and better oral functioning at the 1-year evaluation than nonsurvivors. CONCLUSION: Oral function and denture satisfaction were high and did not change over time for survivors. Deterioration in overall global health and QOL was associated with concurrent comorbidity.
BACKGROUND: The purpose of this prospective study was to assess the quality of life (QOL) and oral functioning of patients with oral cancer up to 5 years after prosthodontic rehabilitation with mandibular implant-retained overdentures. METHODS: Fifty patients who had received implants during ablative surgery were evaluated by standardized questionnaires before and after oncological and prosthetic treatment. RESULTS: In 20 of 24 surviving patients, the dentures were functional after 5 years. In these survivors, oral function remained unchanged during this period. In the 6 patients with concurrent comorbidity, global health and QOL had deteriorated, while in the patients without comorbidity, global health and QOL were very high. Five-year survivors had a higher global health and better oral functioning at the 1-year evaluation than nonsurvivors. CONCLUSION: Oral function and denture satisfaction were high and did not change over time for survivors. Deterioration in overall global health and QOL was associated with concurrent comorbidity.
Authors: Ivana Petrovic; Raymond Baser; Timothy Blackwell; Colleen McCarthy; Ian Ganly; Snehal Patel; Peter Cordeiro; Jatin Shah Journal: Head Neck Date: 2019-02-13 Impact factor: 3.147
Authors: Judit Nagy; Gábor Braunitzer; Márk Antal; Csaba Berkovits; Péter Novák; Katalin Nagy Journal: Qual Life Res Date: 2013-06-04 Impact factor: 4.147
Authors: Reilly J de Groot; Jan-Willem Wetzels; Matthias A W Merkx; Antoine J W P Rosenberg; Anton F J de Haan; Andries van der Bilt; Jan H Abbink; Caroline M Speksnijder Journal: Head Neck Date: 2018-12-15 Impact factor: 3.147
Authors: Reilly J de Groot; Matthias A W Merkx; Merel N S Hamann; Henk S Brand; Anton F J de Haan; Antoine J W P Rosenberg; Caroline M Speksnijder Journal: Support Care Cancer Date: 2019-07-04 Impact factor: 3.603
Authors: Jamie M Alberga; Anke Korfage; Ilse Bonnema; Max J H Witjes; Arjan Vissink; Gerry M Raghoebar Journal: Support Care Cancer Date: 2020-04-11 Impact factor: 3.603
Authors: Matthijs In 't Veld; Engelbert A J M Schulten; Frank K J Leusink Journal: Curr Opin Otolaryngol Head Neck Surg Date: 2021-04-01 Impact factor: 1.814